Review



4 pba  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    MedChemExpress 4 pba
    ER stress induces RCC development and resistance to sunitinib. (A) qPCR (left) and TEM (right) confirming ER stress induction in RCC development. In total, 3 cell line models were used: HK-2 (normal renal epithelial cells), 293T with adriamycin (nephropathy model) and 786-O (clear cell RCC). qPCR markers for ER stress included GRP78, PERK, IRE1α, ATF6 and CHOP. TEM scale bar, 500 nm scale. The levels of ER stress markers are higher in sunitinib resistant (B) 786-O and (C) Caki-1 cells. ER stress phenotype was verified by qPCR (left) and TEM (right, 500 nm scale). (D) Western blot analysis of ER stress markers (p-PERK, PERK, p-IRE1α, IRE1α, p-eIF2α, eIF2α, GRP78, CHOP and ATF6) in 786-O and Caki-1 cell lines with or without sunitinib resistance, showing activation of ER stress pathways. ACTB served as the loading control. Treatment <t>with</t> <t>4-PBA</t> (ER stress inhibitor) was included as an experimental control. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. ER, endoplasmic reticulum; TEM, transmission electron microscopy; RCC, renal cell carcinoma; qPCR, quantitative PCR; GRP78, glucose-regulated protein 78; PERK, protein kinase R-like endoplasmic reticulum kinase; IRE1α, inositol-requiring enzyme 1α; ATF6, activating transcription factor 6; CHOP, C/EBP homologous protein; ACTB, actin beta; p-, phosphorylated.
    4 Pba, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 308 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/4+pba/4-Phenylbutyric+acid/pmc13347009-122-8-21
    Average 97 stars, based on 308 article reviews
    4 pba - by Bioz Stars, 2026-08
    97/100 stars

    Images

    1) Product Images from "A genome-wide Mendelian randomization study focusing on endoplasmic reticulum stress reveals novel genetic markers for renal cell carcinoma"

    Article Title: A genome-wide Mendelian randomization study focusing on endoplasmic reticulum stress reveals novel genetic markers for renal cell carcinoma

    Journal: Oncology Letters

    doi: 10.3892/ol.2026.15732

    ER stress induces RCC development and resistance to sunitinib. (A) qPCR (left) and TEM (right) confirming ER stress induction in RCC development. In total, 3 cell line models were used: HK-2 (normal renal epithelial cells), 293T with adriamycin (nephropathy model) and 786-O (clear cell RCC). qPCR markers for ER stress included GRP78, PERK, IRE1α, ATF6 and CHOP. TEM scale bar, 500 nm scale. The levels of ER stress markers are higher in sunitinib resistant (B) 786-O and (C) Caki-1 cells. ER stress phenotype was verified by qPCR (left) and TEM (right, 500 nm scale). (D) Western blot analysis of ER stress markers (p-PERK, PERK, p-IRE1α, IRE1α, p-eIF2α, eIF2α, GRP78, CHOP and ATF6) in 786-O and Caki-1 cell lines with or without sunitinib resistance, showing activation of ER stress pathways. ACTB served as the loading control. Treatment with 4-PBA (ER stress inhibitor) was included as an experimental control. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. ER, endoplasmic reticulum; TEM, transmission electron microscopy; RCC, renal cell carcinoma; qPCR, quantitative PCR; GRP78, glucose-regulated protein 78; PERK, protein kinase R-like endoplasmic reticulum kinase; IRE1α, inositol-requiring enzyme 1α; ATF6, activating transcription factor 6; CHOP, C/EBP homologous protein; ACTB, actin beta; p-, phosphorylated.
    Figure Legend Snippet: ER stress induces RCC development and resistance to sunitinib. (A) qPCR (left) and TEM (right) confirming ER stress induction in RCC development. In total, 3 cell line models were used: HK-2 (normal renal epithelial cells), 293T with adriamycin (nephropathy model) and 786-O (clear cell RCC). qPCR markers for ER stress included GRP78, PERK, IRE1α, ATF6 and CHOP. TEM scale bar, 500 nm scale. The levels of ER stress markers are higher in sunitinib resistant (B) 786-O and (C) Caki-1 cells. ER stress phenotype was verified by qPCR (left) and TEM (right, 500 nm scale). (D) Western blot analysis of ER stress markers (p-PERK, PERK, p-IRE1α, IRE1α, p-eIF2α, eIF2α, GRP78, CHOP and ATF6) in 786-O and Caki-1 cell lines with or without sunitinib resistance, showing activation of ER stress pathways. ACTB served as the loading control. Treatment with 4-PBA (ER stress inhibitor) was included as an experimental control. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. ER, endoplasmic reticulum; TEM, transmission electron microscopy; RCC, renal cell carcinoma; qPCR, quantitative PCR; GRP78, glucose-regulated protein 78; PERK, protein kinase R-like endoplasmic reticulum kinase; IRE1α, inositol-requiring enzyme 1α; ATF6, activating transcription factor 6; CHOP, C/EBP homologous protein; ACTB, actin beta; p-, phosphorylated.

    Techniques Used: Western Blot, Activation Assay, Control, Transmission Assay, Electron Microscopy, Real-time Polymerase Chain Reaction



    Similar Products

    97
    MedChemExpress 4 pba
    ER stress induces RCC development and resistance to sunitinib. (A) qPCR (left) and TEM (right) confirming ER stress induction in RCC development. In total, 3 cell line models were used: HK-2 (normal renal epithelial cells), 293T with adriamycin (nephropathy model) and 786-O (clear cell RCC). qPCR markers for ER stress included GRP78, PERK, IRE1α, ATF6 and CHOP. TEM scale bar, 500 nm scale. The levels of ER stress markers are higher in sunitinib resistant (B) 786-O and (C) Caki-1 cells. ER stress phenotype was verified by qPCR (left) and TEM (right, 500 nm scale). (D) Western blot analysis of ER stress markers (p-PERK, PERK, p-IRE1α, IRE1α, p-eIF2α, eIF2α, GRP78, CHOP and ATF6) in 786-O and Caki-1 cell lines with or without sunitinib resistance, showing activation of ER stress pathways. ACTB served as the loading control. Treatment <t>with</t> <t>4-PBA</t> (ER stress inhibitor) was included as an experimental control. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. ER, endoplasmic reticulum; TEM, transmission electron microscopy; RCC, renal cell carcinoma; qPCR, quantitative PCR; GRP78, glucose-regulated protein 78; PERK, protein kinase R-like endoplasmic reticulum kinase; IRE1α, inositol-requiring enzyme 1α; ATF6, activating transcription factor 6; CHOP, C/EBP homologous protein; ACTB, actin beta; p-, phosphorylated.
    4 Pba, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/4+pba/4-Phenylbutyric+acid/pmc13347009-122-8-21
    Average 97 stars, based on 1 article reviews
    4 pba - by Bioz Stars, 2026-08
    97/100 stars
      Buy from Supplier

    97
    MedChemExpress 4 phenylbutiryc acid 4 pba
    a. Brief description of the workflow. SH-SY5Y cells were pretreated or not <t>with</t> <t>4-PBA</t> for 48 hours and with NCC 55-0936 for 24 hours. Then, the cells were infected with HSV-1 strain McIntyre at an MOI of 0.1 and analyzed using high content confocal microscopy, viral yield and western blot analysis. b. Panel of confocal microscopy images representing the diQerent conditions. Peroxisomes were labelled using PEX14 (orange), HSV-1 using HSV-1 gD (green), nuclei using DAPI (blue), and cytoskeleton using phalloidin (red). Images were acquired using a 40x magnification. Each data point represents the mean value obtained analysing > 8×10 3 cells. c. Analysis of number of peroxisomes per cell after the treatment with 4-PBA and DMSO. d. Morphological analysis of peroxisomes expressed as spot area, width to length ratio, and roundness after the treatment with 4-PBA. e. Analysis of the percentage of infected cells 4-PBA and NCC 55-0396 treated compared to the vehicle treated control. f. Analyses of peroxisomes per cell after the treatment with NCC 55-0396 and DMSO as vehicle control. g. Viral titer of the cell treated with 4-PBA and DMSO expressed as PFU/mL. h. Viral titer of the cell treated with NCC 55-0396 and DMSO expressed as PFU/mL. i. Western blot analysis on HSV-1 gD content following treatments. GAPDH was used as loading control. Results are expressed as mean ± SD of independent replicates. Data were analysed with One-Way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001; **** p < 0.0001)
    4 Phenylbutiryc Acid 4 Pba, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/4+pba/4-Phenylbutyric+acid/bio_rxiv__64898__2026__06__23__732381-27-9-12
    Average 97 stars, based on 1 article reviews
    4 phenylbutiryc acid 4 pba - by Bioz Stars, 2026-08
    97/100 stars
      Buy from Supplier

    99
    MedChemExpress acid 4 pba
    a. Brief description of the workflow. SH-SY5Y cells were pretreated or not <t>with</t> <t>4-PBA</t> for 48 hours and with NCC 55-0936 for 24 hours. Then, the cells were infected with HSV-1 strain McIntyre at an MOI of 0.1 and analyzed using high content confocal microscopy, viral yield and western blot analysis. b. Panel of confocal microscopy images representing the diQerent conditions. Peroxisomes were labelled using PEX14 (orange), HSV-1 using HSV-1 gD (green), nuclei using DAPI (blue), and cytoskeleton using phalloidin (red). Images were acquired using a 40x magnification. Each data point represents the mean value obtained analysing > 8×10 3 cells. c. Analysis of number of peroxisomes per cell after the treatment with 4-PBA and DMSO. d. Morphological analysis of peroxisomes expressed as spot area, width to length ratio, and roundness after the treatment with 4-PBA. e. Analysis of the percentage of infected cells 4-PBA and NCC 55-0396 treated compared to the vehicle treated control. f. Analyses of peroxisomes per cell after the treatment with NCC 55-0396 and DMSO as vehicle control. g. Viral titer of the cell treated with 4-PBA and DMSO expressed as PFU/mL. h. Viral titer of the cell treated with NCC 55-0396 and DMSO expressed as PFU/mL. i. Western blot analysis on HSV-1 gD content following treatments. GAPDH was used as loading control. Results are expressed as mean ± SD of independent replicates. Data were analysed with One-Way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001; **** p < 0.0001)
    Acid 4 Pba, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/4+pba/Chloroquine/pm42275878-55-5-27
    Average 99 stars, based on 1 article reviews
    acid 4 pba - by Bioz Stars, 2026-08
    99/100 stars
      Buy from Supplier

    97
    MedChemExpress pba
    a. Brief description of the workflow. SH-SY5Y cells were pretreated or not <t>with</t> <t>4-PBA</t> for 48 hours and with NCC 55-0936 for 24 hours. Then, the cells were infected with HSV-1 strain McIntyre at an MOI of 0.1 and analyzed using high content confocal microscopy, viral yield and western blot analysis. b. Panel of confocal microscopy images representing the diQerent conditions. Peroxisomes were labelled using PEX14 (orange), HSV-1 using HSV-1 gD (green), nuclei using DAPI (blue), and cytoskeleton using phalloidin (red). Images were acquired using a 40x magnification. Each data point represents the mean value obtained analysing > 8×10 3 cells. c. Analysis of number of peroxisomes per cell after the treatment with 4-PBA and DMSO. d. Morphological analysis of peroxisomes expressed as spot area, width to length ratio, and roundness after the treatment with 4-PBA. e. Analysis of the percentage of infected cells 4-PBA and NCC 55-0396 treated compared to the vehicle treated control. f. Analyses of peroxisomes per cell after the treatment with NCC 55-0396 and DMSO as vehicle control. g. Viral titer of the cell treated with 4-PBA and DMSO expressed as PFU/mL. h. Viral titer of the cell treated with NCC 55-0396 and DMSO expressed as PFU/mL. i. Western blot analysis on HSV-1 gD content following treatments. GAPDH was used as loading control. Results are expressed as mean ± SD of independent replicates. Data were analysed with One-Way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001; **** p < 0.0001)
    Pba, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/4+pba/4-Phenylbutyric+acid/pm42209521-663-6-23
    Average 97 stars, based on 1 article reviews
    pba - by Bioz Stars, 2026-08
    97/100 stars
      Buy from Supplier

    94
    TargetMol pba chemical chaperone targetmol t5886
    a. Brief description of the workflow. SH-SY5Y cells were pretreated or not <t>with</t> <t>4-PBA</t> for 48 hours and with NCC 55-0936 for 24 hours. Then, the cells were infected with HSV-1 strain McIntyre at an MOI of 0.1 and analyzed using high content confocal microscopy, viral yield and western blot analysis. b. Panel of confocal microscopy images representing the diQerent conditions. Peroxisomes were labelled using PEX14 (orange), HSV-1 using HSV-1 gD (green), nuclei using DAPI (blue), and cytoskeleton using phalloidin (red). Images were acquired using a 40x magnification. Each data point represents the mean value obtained analysing > 8×10 3 cells. c. Analysis of number of peroxisomes per cell after the treatment with 4-PBA and DMSO. d. Morphological analysis of peroxisomes expressed as spot area, width to length ratio, and roundness after the treatment with 4-PBA. e. Analysis of the percentage of infected cells 4-PBA and NCC 55-0396 treated compared to the vehicle treated control. f. Analyses of peroxisomes per cell after the treatment with NCC 55-0396 and DMSO as vehicle control. g. Viral titer of the cell treated with 4-PBA and DMSO expressed as PFU/mL. h. Viral titer of the cell treated with NCC 55-0396 and DMSO expressed as PFU/mL. i. Western blot analysis on HSV-1 gD content following treatments. GAPDH was used as loading control. Results are expressed as mean ± SD of independent replicates. Data were analysed with One-Way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001; **** p < 0.0001)
    Pba Chemical Chaperone Targetmol T5886, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/4+pba/4-Phenylbutyric+acid/pm41947198-748-142-145
    Average 94 stars, based on 1 article reviews
    pba chemical chaperone targetmol t5886 - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    97
    MedChemExpress pba 4 pba
    a. Brief description of the workflow. SH-SY5Y cells were pretreated or not <t>with</t> <t>4-PBA</t> for 48 hours and with NCC 55-0936 for 24 hours. Then, the cells were infected with HSV-1 strain McIntyre at an MOI of 0.1 and analyzed using high content confocal microscopy, viral yield and western blot analysis. b. Panel of confocal microscopy images representing the diQerent conditions. Peroxisomes were labelled using PEX14 (orange), HSV-1 using HSV-1 gD (green), nuclei using DAPI (blue), and cytoskeleton using phalloidin (red). Images were acquired using a 40x magnification. Each data point represents the mean value obtained analysing > 8×10 3 cells. c. Analysis of number of peroxisomes per cell after the treatment with 4-PBA and DMSO. d. Morphological analysis of peroxisomes expressed as spot area, width to length ratio, and roundness after the treatment with 4-PBA. e. Analysis of the percentage of infected cells 4-PBA and NCC 55-0396 treated compared to the vehicle treated control. f. Analyses of peroxisomes per cell after the treatment with NCC 55-0396 and DMSO as vehicle control. g. Viral titer of the cell treated with 4-PBA and DMSO expressed as PFU/mL. h. Viral titer of the cell treated with NCC 55-0396 and DMSO expressed as PFU/mL. i. Western blot analysis on HSV-1 gD content following treatments. GAPDH was used as loading control. Results are expressed as mean ± SD of independent replicates. Data were analysed with One-Way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001; **** p < 0.0001)
    Pba 4 Pba, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/4+pba/4-Phenylbutyric+acid/pm41910728-53-0-5
    Average 97 stars, based on 1 article reviews
    pba 4 pba - by Bioz Stars, 2026-08
    97/100 stars
      Buy from Supplier

    Image Search Results


    ER stress induces RCC development and resistance to sunitinib. (A) qPCR (left) and TEM (right) confirming ER stress induction in RCC development. In total, 3 cell line models were used: HK-2 (normal renal epithelial cells), 293T with adriamycin (nephropathy model) and 786-O (clear cell RCC). qPCR markers for ER stress included GRP78, PERK, IRE1α, ATF6 and CHOP. TEM scale bar, 500 nm scale. The levels of ER stress markers are higher in sunitinib resistant (B) 786-O and (C) Caki-1 cells. ER stress phenotype was verified by qPCR (left) and TEM (right, 500 nm scale). (D) Western blot analysis of ER stress markers (p-PERK, PERK, p-IRE1α, IRE1α, p-eIF2α, eIF2α, GRP78, CHOP and ATF6) in 786-O and Caki-1 cell lines with or without sunitinib resistance, showing activation of ER stress pathways. ACTB served as the loading control. Treatment with 4-PBA (ER stress inhibitor) was included as an experimental control. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. ER, endoplasmic reticulum; TEM, transmission electron microscopy; RCC, renal cell carcinoma; qPCR, quantitative PCR; GRP78, glucose-regulated protein 78; PERK, protein kinase R-like endoplasmic reticulum kinase; IRE1α, inositol-requiring enzyme 1α; ATF6, activating transcription factor 6; CHOP, C/EBP homologous protein; ACTB, actin beta; p-, phosphorylated.

    Journal: Oncology Letters

    Article Title: A genome-wide Mendelian randomization study focusing on endoplasmic reticulum stress reveals novel genetic markers for renal cell carcinoma

    doi: 10.3892/ol.2026.15732

    Figure Lengend Snippet: ER stress induces RCC development and resistance to sunitinib. (A) qPCR (left) and TEM (right) confirming ER stress induction in RCC development. In total, 3 cell line models were used: HK-2 (normal renal epithelial cells), 293T with adriamycin (nephropathy model) and 786-O (clear cell RCC). qPCR markers for ER stress included GRP78, PERK, IRE1α, ATF6 and CHOP. TEM scale bar, 500 nm scale. The levels of ER stress markers are higher in sunitinib resistant (B) 786-O and (C) Caki-1 cells. ER stress phenotype was verified by qPCR (left) and TEM (right, 500 nm scale). (D) Western blot analysis of ER stress markers (p-PERK, PERK, p-IRE1α, IRE1α, p-eIF2α, eIF2α, GRP78, CHOP and ATF6) in 786-O and Caki-1 cell lines with or without sunitinib resistance, showing activation of ER stress pathways. ACTB served as the loading control. Treatment with 4-PBA (ER stress inhibitor) was included as an experimental control. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. ER, endoplasmic reticulum; TEM, transmission electron microscopy; RCC, renal cell carcinoma; qPCR, quantitative PCR; GRP78, glucose-regulated protein 78; PERK, protein kinase R-like endoplasmic reticulum kinase; IRE1α, inositol-requiring enzyme 1α; ATF6, activating transcription factor 6; CHOP, C/EBP homologous protein; ACTB, actin beta; p-, phosphorylated.

    Article Snippet: For ER stress inhibition, cells were pretreated with 4-PBA (2 mM, 24 h, at 37°C in a 5% CO 2 atmosphere; MedChemExpress; cat. no. HY-A2081) prior to protein extraction.

    Techniques: Western Blot, Activation Assay, Control, Transmission Assay, Electron Microscopy, Real-time Polymerase Chain Reaction

    a. Brief description of the workflow. SH-SY5Y cells were pretreated or not with 4-PBA for 48 hours and with NCC 55-0936 for 24 hours. Then, the cells were infected with HSV-1 strain McIntyre at an MOI of 0.1 and analyzed using high content confocal microscopy, viral yield and western blot analysis. b. Panel of confocal microscopy images representing the diQerent conditions. Peroxisomes were labelled using PEX14 (orange), HSV-1 using HSV-1 gD (green), nuclei using DAPI (blue), and cytoskeleton using phalloidin (red). Images were acquired using a 40x magnification. Each data point represents the mean value obtained analysing > 8×10 3 cells. c. Analysis of number of peroxisomes per cell after the treatment with 4-PBA and DMSO. d. Morphological analysis of peroxisomes expressed as spot area, width to length ratio, and roundness after the treatment with 4-PBA. e. Analysis of the percentage of infected cells 4-PBA and NCC 55-0396 treated compared to the vehicle treated control. f. Analyses of peroxisomes per cell after the treatment with NCC 55-0396 and DMSO as vehicle control. g. Viral titer of the cell treated with 4-PBA and DMSO expressed as PFU/mL. h. Viral titer of the cell treated with NCC 55-0396 and DMSO expressed as PFU/mL. i. Western blot analysis on HSV-1 gD content following treatments. GAPDH was used as loading control. Results are expressed as mean ± SD of independent replicates. Data were analysed with One-Way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001; **** p < 0.0001)

    Journal: bioRxiv

    Article Title: Peroxisome dynamics during HSV-1 life cycle in human neurons

    doi: 10.64898/2026.06.23.732381

    Figure Lengend Snippet: a. Brief description of the workflow. SH-SY5Y cells were pretreated or not with 4-PBA for 48 hours and with NCC 55-0936 for 24 hours. Then, the cells were infected with HSV-1 strain McIntyre at an MOI of 0.1 and analyzed using high content confocal microscopy, viral yield and western blot analysis. b. Panel of confocal microscopy images representing the diQerent conditions. Peroxisomes were labelled using PEX14 (orange), HSV-1 using HSV-1 gD (green), nuclei using DAPI (blue), and cytoskeleton using phalloidin (red). Images were acquired using a 40x magnification. Each data point represents the mean value obtained analysing > 8×10 3 cells. c. Analysis of number of peroxisomes per cell after the treatment with 4-PBA and DMSO. d. Morphological analysis of peroxisomes expressed as spot area, width to length ratio, and roundness after the treatment with 4-PBA. e. Analysis of the percentage of infected cells 4-PBA and NCC 55-0396 treated compared to the vehicle treated control. f. Analyses of peroxisomes per cell after the treatment with NCC 55-0396 and DMSO as vehicle control. g. Viral titer of the cell treated with 4-PBA and DMSO expressed as PFU/mL. h. Viral titer of the cell treated with NCC 55-0396 and DMSO expressed as PFU/mL. i. Western blot analysis on HSV-1 gD content following treatments. GAPDH was used as loading control. Results are expressed as mean ± SD of independent replicates. Data were analysed with One-Way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001; **** p < 0.0001)

    Article Snippet: For peroxisome modulation, cells were treated with 3 mM 4-phenylbutiryc acid (4-PBA) (MedChemExpress, USA, #Cat 1821-12-1) for 48 hours or NCC 55-0396 (MedChemExpress, USA, #Cat 357400) for 24 hours before HSV-1 inoculation and after the infection.

    Techniques: Infection, Confocal Microscopy, Western Blot, Control

    a. Schematic representation of AGPS KO cell generation. b. Western blot image showing the AGPS KO generation. c. Schematic representation of the workflow. SH-SY5Y cells were pretreated or not with 4-PBA for 48 hours and with NCC 55-0936 for 24 hours. Then, the cells were infected with HSV-1 strain McIntyre at an MOI of 0.1 and analyzed using high content confocal microscopy and viral yield d. Panel of confocal microscopy images representing the diQerent conditions. HSV-1 using HSV-1 gD (red) and nuclei using DAPI (blue). Images were acquired using a 20x magnification. Each data point represents the mean value obtained analysing > 8×10 3 cells. e. Analysis of the % of infected cells among the diQerent conditions: SH-SY5Y WT, AGPS KO treated or not with 4-PBA. f. Representative images of viral yield assay plate for each analyzed condition. g. Quantification of HSV-1 viral titer expressed as PFU/mL in the diQerent samples. Each data point represents a single experiment.

    Journal: bioRxiv

    Article Title: Peroxisome dynamics during HSV-1 life cycle in human neurons

    doi: 10.64898/2026.06.23.732381

    Figure Lengend Snippet: a. Schematic representation of AGPS KO cell generation. b. Western blot image showing the AGPS KO generation. c. Schematic representation of the workflow. SH-SY5Y cells were pretreated or not with 4-PBA for 48 hours and with NCC 55-0936 for 24 hours. Then, the cells were infected with HSV-1 strain McIntyre at an MOI of 0.1 and analyzed using high content confocal microscopy and viral yield d. Panel of confocal microscopy images representing the diQerent conditions. HSV-1 using HSV-1 gD (red) and nuclei using DAPI (blue). Images were acquired using a 20x magnification. Each data point represents the mean value obtained analysing > 8×10 3 cells. e. Analysis of the % of infected cells among the diQerent conditions: SH-SY5Y WT, AGPS KO treated or not with 4-PBA. f. Representative images of viral yield assay plate for each analyzed condition. g. Quantification of HSV-1 viral titer expressed as PFU/mL in the diQerent samples. Each data point represents a single experiment.

    Article Snippet: For peroxisome modulation, cells were treated with 3 mM 4-phenylbutiryc acid (4-PBA) (MedChemExpress, USA, #Cat 1821-12-1) for 48 hours or NCC 55-0396 (MedChemExpress, USA, #Cat 357400) for 24 hours before HSV-1 inoculation and after the infection.

    Techniques: Western Blot, Infection, Confocal Microscopy